Delisting risk
Reviva Pharmaceuticals
Develops brilaroxazine-led therapies for CNS, inflammatory, and cardiometabolic diseases.
$0.5150
After-hours close−0.00 (−0.68%)
At close$0.5185(+2.78%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.29 | — | — |
| Aug 2026 | −$0.39 | −$0.19 | +50.6% |
| Aug 2026 | −$0.39 | −$0.19 | +50.6% |
| May 2026 | −$0.75 | −$0.46 | +38.7% |
| Mar 2026 | −$1.08 | $0.72 | +166.7% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| May 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.29 | — | — | — | — | — |
| Aug 13, 2026 | −$0.39 | −$0.19 | +50.6% | — | — | — |
| Aug 12, 2026 | −$0.39 | −$0.19 | +50.6% | — | — | — |
| May 14, 2026 | −$0.75 | −$0.46 | +38.7% | — | — | — |
| Mar 30, 2026 | −$1.08 | $0.72 | +166.7% | — | — | — |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | ||||||
| Nov 13, 2025 | ||||||
| Aug 14, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 14, 2024 | ||||||
| Apr 15, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 15, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 17, 2021 | ||||||
| Mar 22, 2021 | ||||||
| Sep 14, 2020 | ||||||
| Jul 7, 2020 | ||||||
| May 2, 2020 | ||||||
| Jan 10, 2020 | ||||||
| Oct 8, 2019 | ||||||
| Jul 3, 2019 | ||||||
| May 22, 2019 | ||||||
| Jan 9, 2019 | ||||||
| Oct 11, 2018 | ||||||
| May 31, 2018 | ||||||